Joint Session of the ESR and EORTC

Imaging and treatment of oligometastatic breast cancer

Lectures

1
ESR-EORTC-1 - Chairperson's introduction

ESR-EORTC-1 - Chairperson's introduction

04:02Nandita M. deSouza

2
ESR-EORTC-2 - Clinical relevance of oligometastatic disease in breast cancer patients

ESR-EORTC-2 - Clinical relevance of oligometastatic disease in breast cancer patients

15:31David Pasquier

1. To learn about the definition of oligometastatic disease.
2. To appreciate the therapeutic potentials of radiation oncology for oligometastatic disease.
3. To understand the clinical relevance of oligometastatic breast cancer.

3
ESR-EORTC-3 - Advanced imaging and future perspective in oligometastatic breast cancer

ESR-EORTC-3 - Advanced imaging and future perspective in oligometastatic breast cancer

17:21Lioe Fee de Geus-Oei

1. To learn about the current standards in breast cancer imaging.
2. To appreciate the differences in the diagnostic performance of the available imaging modalities for lesion detection in oligometastatic breast cancer.
3. To understand the future developments in diagnostic imaging for breast cancer detection.

4
ESR-EORTC-4 - Incorporating advanced imaging into clinical trials EORCT IG recommendations

ESR-EORTC-4 - Incorporating advanced imaging into clinical trials EORCT IG recommendations

19:07Frédéric E. Lecouvet

1. To become aware of the impact of imaging generation on patient stratification and response assessment.
2. To appreciate the role of imaging for end-points evaluation in clinical trials and research.
3. To understand how to design trials evaluating optimal imaging strategies in oligometastatic breast cancer.

5
ESR-EORTC-5 - Panel discussion

ESR-EORTC-5 - Panel discussion

06:18